209 related articles for article (PubMed ID: 23545288)
101. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
102. Targeting of AIDS related encephalopathy using phenylalanine anchored lipidic nanocarrier.
Vyas A; Jain A; Hurkat P; Jain A; Jain SK
Colloids Surf B Biointerfaces; 2015 Jul; 131():155-61. PubMed ID: 25988279
[TBL] [Abstract][Full Text] [Related]
103. Tailoring Lipid and Polymeric Nanoparticles as siRNA Carriers towards the Blood-Brain Barrier - from Targeting to Safe Administration.
Gomes MJ; Fernandes C; Martins S; Borges F; Sarmento B
J Neuroimmune Pharmacol; 2017 Mar; 12(1):107-119. PubMed ID: 27209050
[TBL] [Abstract][Full Text] [Related]
104. Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain.
Kakkar V; Mishra AK; Chuttani K; Kaur IP
Int J Pharm; 2013 May; 448(2):354-9. PubMed ID: 23558314
[TBL] [Abstract][Full Text] [Related]
105. Enhanced brain targeting efficacy of Olanzapine through solid lipid nanoparticles.
Natarajan J; Baskaran M; Humtsoe LC; Vadivelan R; Justin A
Artif Cells Nanomed Biotechnol; 2017 Mar; 45(2):364-371. PubMed ID: 27002542
[TBL] [Abstract][Full Text] [Related]
106. Intracellular trafficking of solid lipid nanoparticles and their distribution between cells through tunneling nanotubes.
Kristl J; Plajnšek KT; Kreft ME; Janković B; Kocbek P
Eur J Pharm Sci; 2013 Sep; 50(1):139-48. PubMed ID: 23628779
[TBL] [Abstract][Full Text] [Related]
107. Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer's Disease.
Loureiro JA; Andrade S; Duarte A; Neves AR; Queiroz JF; Nunes C; Sevin E; Fenart L; Gosselet F; Coelho MA; Pereira MC
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208831
[TBL] [Abstract][Full Text] [Related]
108. Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E.
Neves AR; Queiroz JF; Reis S
J Nanobiotechnology; 2016 Apr; 14():27. PubMed ID: 27061902
[TBL] [Abstract][Full Text] [Related]
109. Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression.
He X; Zhu Y; Wang M; Jing G; Zhu R; Wang S
Int J Nanomedicine; 2016; 11():4975-4990. PubMed ID: 27757031
[TBL] [Abstract][Full Text] [Related]
110. Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles.
Gao H; Yang Z; Zhang S; Pang Z; Jiang X
J Drug Target; 2014 Jun; 22(5):450-9. PubMed ID: 24512500
[TBL] [Abstract][Full Text] [Related]
111. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
[TBL] [Abstract][Full Text] [Related]
112. Novel targeted siRNA-loaded hybrid nanoparticles: preparation, characterization and in vitro evaluation.
Dim N; Perepelyuk M; Gomes O; Thangavel C; Liu Y; Den R; Lakshmikuttyamma A; Shoyele SA
J Nanobiotechnology; 2015 Sep; 13():61. PubMed ID: 26410728
[TBL] [Abstract][Full Text] [Related]
113. Nanosized Cubosomal Thermogelling Dispersion Loaded with Saquinavir Mesylate to Improve Its Bioavailability: Preparation, Optimization, in vitro and in vivo Evaluation.
Hosny KM
Int J Nanomedicine; 2020; 15():5113-5129. PubMed ID: 32764940
[TBL] [Abstract][Full Text] [Related]
114. Transport mechanism of lipid covered saquinavir pure drug nanoparticles in intestinal epithelium.
Xia D; He Y; Li Q; Hu C; Huang W; Zhang Y; Wan F; Wang C; Gan Y
J Control Release; 2018 Jan; 269():159-170. PubMed ID: 29129657
[TBL] [Abstract][Full Text] [Related]
115. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
[TBL] [Abstract][Full Text] [Related]
116. Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease.
Pinheiro RGR; Granja A; Loureiro JA; Pereira MC; Pinheiro M; Neves AR; Reis S
Eur J Pharm Sci; 2020 May; 148():105314. PubMed ID: 32200044
[TBL] [Abstract][Full Text] [Related]
117. Enhanced permeability of blood-brain barrier and targeting function of brain via borneol-modified chemically solid lipid nanoparticle.
Song H; Wei M; Zhang N; Li H; Tan X; Zhang Y; Zheng W
Int J Nanomedicine; 2018; 13():1869-1879. PubMed ID: 29636606
[TBL] [Abstract][Full Text] [Related]
118. Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S
Nanomedicine (Lond); 2014 Apr; 9(5):709-22. PubMed ID: 24827845
[TBL] [Abstract][Full Text] [Related]
119. Enhanced blood brain barrier permeability and glioblastoma cell targeting via thermoresponsive lipid nanoparticles.
Rehman M; Madni A; Shi D; Ihsan A; Tahir N; Chang KR; Javed I; Webster TJ
Nanoscale; 2017 Oct; 9(40):15434-15440. PubMed ID: 28976512
[TBL] [Abstract][Full Text] [Related]
120. Anti-Aβ-MAb and dually decorated nanoliposomes: effect of Aβ1-42 peptides on interaction with hCMEC/D3 cells.
Markoutsa E; Papadia K; Clemente C; Flores O; Antimisiaris SG
Eur J Pharm Biopharm; 2012 May; 81(1):49-56. PubMed ID: 22386910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
